Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05630066 |
|---|---|
| Brief Title: | Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. (Aldebaran) |
| First Submitted : | November 9, 2022 |
| First Submitted that Met QC Criteria : | November 17, 2022 |
| First Posted : | November 29, 2022 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |